Immunohistochemistry (IHC) Market Outlook 2025–2030: Innovation, Automation & Precision Diagnostics Fuel a New Era in Cancer Care
The global Immunohistochemistry (IHC) Market continues to accelerate, driven by rising cancer incidence, rapid adoption of automated pathology systems, and the growing demand for personalized medicine. Valued at US$3.31 billion in 2024 and rising to US$3.55 billion in 2025, the market is on track to reach US$5.14 billion by 2030, expanding at a robust CAGR of 7.6%.
With oncology becoming increasingly...
Immunohistochemistry: The Next Growth Frontier in Diagnostics & Precision Medicine
Immunohistochemistry: The Next Growth Frontier in Diagnostics & Precision MedicineThe global Immunohistochemistry (IHC) market is on track to reach USD 5.14 billion by 2030, up from USD 3.55 billion in 2025, at a CAGR of 7.6%.
For healthcare and biopharma leaders, this growth isn’t just about market expansion — it’s a signal of how IHC is transforming oncology, pathology, and precision...
Emerging Trends Tissue Diagnostics Market by Types, Revenue, Industry Growth and Forecast 2022
The growing incidence of cancer along with a rapidly aging population, technological advancements in tissue diagnostics techniques, and increasing healthcare expenditure are key factors driving the growth of the tissue diagnostics market.
The tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.44 Billion in 2016 at a CAGR of 6.9%.
+ Market Dynamics +...

